Sentry Investment Management LLC Biogen Inc. Transaction History

Sentry Investment Management LLC

$238 Million
Q3 2024

A detailed history of Sentry Investment Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Sentry Investment Management LLC holds 685 shares of BIIB stock, worth $110,031. This represents 0.06% of its overall portfolio holdings.

Number of Shares

685

Previous 422 62.32%

Holding current value

$110,031

Previous $98,000 35.71%

% of portfolio

0.06%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$189.07 - $236.8 $49,725 - $62,278	263 Added 62.32%	685 $133,000
Q2 2024 Aug 07, 2024	SELL	$190.52 - $236.72 $64,014 - $79,537	-336 Reduced 44.33%	422 $98,000
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $18,029 - $21,703	-81 Reduced 9.65%	758 $196,000
Q3 2023 Nov 03, 2023	SELL	$253.3 - $285.89 $28,876 - $32,591	-114 Reduced 11.96%	839 $216,000
Q1 2023 Apr 26, 2023	SELL	$256.56 - $292.34 $6,670 - $7,600	-26 Reduced 2.66%	953 $265,000
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $35,820 - $42,596	-191 Reduced 16.32%	979 $200,000
Q1 2022 May 09, 2022	SELL	$193.77 - $244.14 $44,179 - $55,663	-228 Reduced 16.31%	1,170 $246,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $34,483 - $44,316	154 Added 12.38%	1,398 $335,000
Q3 2021 Nov 03, 2021	SELL	$282.99 - $369.05 $51,504 - $67,167	-182 Reduced 12.76%	1,244 $352,000
Q2 2021 Aug 04, 2021	SELL	$259.0 - $414.71 $61,383 - $98,286	-237 Reduced 14.25%	1,426 $494,000
Q1 2021 Apr 21, 2021	SELL	$242.95 - $284.63 $2.02 Million - $2.37 Million	-8,319 Reduced 83.34%	1,663 $465,000
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $51,268 - $77,171	-217 Reduced 2.13%	9,982 $2.44 Million
Q3 2020 Nov 05, 2020	SELL	$264.77 - $305.71 $794 - $917	-3 Reduced 0.03%	10,199 $2.89 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $281,680 - $373,036	-1,089 Reduced 9.64%	10,202 $2.73 Million
Q1 2020 May 05, 2020	BUY	$268.85 - $341.04 $159,696 - $202,577	594 Added 5.55%	11,291 $3.57 Million
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $330,291 - $370,453	-1,519 Reduced 12.43%	10,697 $2.49 Million
Q2 2019 Aug 12, 2019	SELL	$219.29 - $241.72 $2.16 Million - $2.38 Million	-9,864 Reduced 44.67%	12,216 $2.86 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $524,654 - $820,622	-2,421 Reduced 9.88%	22,080 $5.22 Million
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $309,970 - $392,610	-1,113 Reduced 4.35%	24,501 $7.37 Million
Q3 2018 Nov 06, 2018	BUY	$293.51 - $383.83 $486,639 - $636,390	1,658 Added 6.92%	25,614 $9.05 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $357,695 - $426,297	-1,389 Reduced 5.48%	23,956 $6.95 Million
Q1 2018 May 02, 2018	SELL	$260.13 - $367.91 $626,913 - $886,663	-2,410 Reduced 8.68%	25,345 $6.94 Million
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $123,671 - $138,521	402 Added 1.47%	27,755 $8.84 Million
Q3 2017 Nov 13, 2017	SELL	$281.15 - $329.69 $3,092 - $3,626	-11 Reduced 0.04%	27,353 $8.57 Million
Q2 2017 Aug 21, 2017	BUY	N/A	27,364	27,364 $7.43 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sentry Investment Management LLC with notifications on news.

Account

Sentry Investment Management LLC Biogen Inc. Transaction History